IPD provides product development innovation, design strategy, advanced R&D and design for commercialization services to medical device, life sciences and connected health customers. Headquartered in France, Nemera provides design, development and manufacturing solutions for drug delivery devices to the pharmaceutical, biotechnology and generics industries. IPD’s presence in the Midwest perfectly complements Nemera’s Center of Excellence in Europe.
The two organizations bring together the strengths of IPD’s front-end innovation, design research, human factors and design engineering with Nemera’s expertise in late-stage development capabilities, as well as clinical and commercial manufacturing capabilities. IPD’s user-centered design capabilities help clients discover, innovate and develop new products and solutions, as evidence by over 250 design & utility patents that the company has developed for clients such as Boston Scientific, Becton Dickinson and Shire Pharmaceuticals. IPD designed products have received multiple Red Dot, IDEA and other award-winning design & innovation recognition over the years.
The transaction is a further testament to Technology Holdings’ expertise in the design & innovation space, having most recently advised on the Continuum-EPAM and Syncroness-ALTEN transactions.